RPG Life Sciences · NSE: RPGLIFE · BSE: 532983
Q4 FY19 results · Jan–Mar 2019
RPG Life Sciences reported revenue from operations of ₹68.80 crore and net profit of ₹1.54 crore for Q4 FY19 (Jan–Mar 2019), on a standalone basis.
| Item | Q4 FY19 | Q4 FY18 | YoY | Q3 FY19 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 68.80 | — | — | 90.97 | −24.4% |
| Other income | 0.42 | — | — | 0.02 | 21x |
| Total income | 69.22 | — | — | 90.99 | −23.9% |
| Profit before tax | 2.12 | — | — | 7.25 | −70.8% |
| Net profit for the period | 1.54 | — | — | 5.28 | −70.8% |
| EPS, basic (₹) | 0.93 | — | — | 3.19 | −70.8% |
| Net margin (%) | 2.2 | — | 5.8 |
Standalone
- Filed with BSE
- 30 Apr 2019, 15:36 IST
- Board meeting
- 29 Apr 2019
- Period
- 01 Jan 2019 to 31 Mar 2019
- Review status
- Audited
- Source
- XBRL filing on BSE